An overview of cancer of the prostate diagnosis and management in Nigeria: The experience in a Nigerian tertiary hospital

被引:22
作者
Ajape, Abdulwahab A. [1 ]
Ibrahim, Kazeem O. O. [2 ]
Fakeye, John A. [2 ]
Abiola, Olusegun O. [1 ]
机构
[1] Univ Ilorin, Teaching Hosp, Dept Surg, Div Urol, POB 4850, Ilorin 240001, Kwara State, Nigeria
[2] Univ Ilorin, Teaching Hosp, Dept Pathol & Morbid Anat, Ilorin, Nigeria
关键词
Cancer of prostate; mode of presentation; outcome; treatment;
D O I
10.4103/1596-3519.68353
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To review our experience with cancer of prostate management, highlighting the mode of presentation, method of diagnosis, and the treatment outcome. Methods: Medical records of patients managed for cancer of prostate were retrospectively reviewed over a 10-year period. Relevant information which included the year of diagnosis, age at presentation, mode of presentation, digital rectal examination (DRE) findings, ultrasound (USS) assessment of the prostate, the prostate-specific antigen (PSA) value, the histology report, treatment offered and the outcome were extracted. Data were analyzed with SPSS version 11 software. Results: A total of 192 patients were managed for cancer of prostate within the study period but only 90 case notes were available for analysis. There was a 7.7 fold increase in the incidence of cancer of prostate. The mean age (SD) at presentation was 68.4 (10.1) years with an age range of 47-91 years and the peak incidence occurred in the seventh and eighth decades of life. The mean duration of symptoms prior to presentation was 10.3 (17.1) months. A total of 66.7% of cases presented within 6 months of the onset of symptoms as against 14.4% of cases presented after a year. Majority of cases (88.9%) presented as locally advanced or metastatic disease and only 4.4% of cases were found incidentally. Only 38.9% had histologic confirmation of the diagnosis before management was instituted. DRE gave a false negative finding in 28.6% in this study. The sensitivity and false negative value of USS was 50% each and 3.3% had PSA within normal value. Bilateral orchidectomy was offered to 64 of 90 (71.1%) and the cancer related death (CRD) was 15.6%. The maximum follow-up period was 36 months in this study and 36.9% are still attending follow-up clinic. Conclusion: There was an apparent increase in the incidence of cancer of prostate from the present study with majority still presenting with advanced disease. The sensitivity of DRE was high; this probably accounted for the treatment without establishing the histologic diagnosis in majority of the cases. Such a practice of clinical diagnosis alone should be discouraged.
引用
收藏
页码:113 / 117
页数:5
相关论文
共 14 条
  • [1] AHLUWALIA B, 1981, CANCER, V48, P2267, DOI 10.1002/1097-0142(19811115)48:10<2267::AID-CNCR2820481023>3.0.CO
  • [2] 2-R
  • [3] New circulating biomarkers for prostate cancer
    Bensalah, K.
    Lotan, Y.
    Karam, J. A.
    Shariat, S. F.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2008, 11 (02) : 112 - 120
  • [4] Benign prostatic hyperplasia and prostate carcinoma in native Africans
    Dawam, D
    Rafindadi, AH
    Kalayi, GD
    [J]. BJU INTERNATIONAL, 2000, 85 (09) : 1074 - 1077
  • [5] Eke N, 2002, NIGER J SURG RES, V4, P34
  • [6] Trends and patterns of prostate cancer: What do they suggest?
    Hsing, AW
    Devesa, SS
    [J]. EPIDEMIOLOGIC REVIEWS, 2001, 23 (01) : 3 - 13
  • [7] JACKSON MA, 1977, CANCER TREAT REP, V61, P167
  • [8] Cancer statistics, 2007
    Jemal, Ahmedin
    Siegel, Rebecca
    Ward, Elizabeth
    Murray, Taylor
    Xu, Jiaquan
    Thun, Michael J.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (01) : 43 - 66
  • [9] SIGNIFICANCE OF THE PALPABLE PROSTATIC NODULE
    JEWETT, HJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1956, 160 (10): : 838 - 839
  • [10] Kirby RS, 2001, FAST FACTS PROSTATE, P30